The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study

BACKGROUND: Immunosuppressive therapies have become a cornerstone of the management of severe COVID-19. The impact of these therapies on secondary infections and antimicrobial prescribing remains unclear. We sought to assess antimicrobial use and the incidence of bacterial and fungal infections in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Crook, Peter, Logan, Clare, Mazzella, Andrea, Wake, Rachel M., Cusinato, Martina, Yau, Ting, Ong, Yee-Ean, Planche, Timothy, Basarab, Marina, Bicanic, Tihana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656831/
https://www.ncbi.nlm.nih.gov/pubmed/37978457
http://dx.doi.org/10.1186/s12879-023-08697-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656831/
https://www.ncbi.nlm.nih.gov/pubmed/37978457
http://dx.doi.org/10.1186/s12879-023-08697-9

Ejemplares similares